IP Library Granted Patent US 9,777,046
Granted Patent B2
US 9,777,046 · App. 14/322,864 · Granted Oct 3, 2017

Repebody against immunoglobulin G and uses thereof

Inventors: Hak-Sung Kim (Daejeon, KR); Woosung Heu (Daejeon, KR); Joong-Jae Lee (Daejeon, KR); Seong-Min Jo (Daejeon, KR)
Assignee: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
C07K14/195C07K14/705C07K16/065C07K2319/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,777,046
App. No.
14/322,864
Granted
Oct 3, 2017
Kind
B2
Abstract

The present invention relates to a polypeptide (repebody) selectively bound to an immunoglobulin G, a polynucleotide which encodes the repebody, a vector containing the polynucleotide, a recombinant microorganism in which the polynucleotide is introduced, a method for producing the repebody using the recombinant microorganism, and a method for immobilizing or purifying an immunoglobulin G using the repebody. The repebody according to the present invention is useful as utilized for immobilization of an immunoglobulin G, purification of an immunoglobulin G, and production of an immunosensor, since the repebody selectively bound to an immunoglobulin G.

Claims (8)

1. A repebody consisting of the amino acid sequence of SEQ ID NO: 3, wherein the repebody is capable of selectively binding to immunoglobulin G.

2. A repebody consisting of the amino acid sequence of SEQ ID NOs: 4 or 5, wherein the repebody is capable of selectively binding to immunoglobulin G.

3. A polynucleotide which encodes the repebody of claim 1 .

4. A vector which contains the polynucleotide of claim 3 .

5. A recombinant microorganism, in which the polynucleotide of claim 3 , or a vector containing said polynucleotide, is introduced.

6. A method for producing the repebody of claim 1 , wherein the method comprises:

(i) expressing the repebody by culturing the recombinant microorganism of claim 5 ; and

(ii) recovering the expressed repebody.

Assignments (3)
CHANGE OF NAME Recorded Nov 11, 2020
From: REPIGEN
To: PROEN THERAPEUTICS INC.
Reel/Frame 054388/0422 →
LICENSE Recorded Jun 17, 2019
From: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
To: REPIGEN
Reel/Frame 049488/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2014
From: KIM, HAK-SUNG; HEU, WOOSUNG; LEE, JOONG-JAE; JO, SEONG-MIN
To: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
Reel/Frame 033256/0680 →
Priority Claims (1)
KR 10-2013-0081009 · Jul 10, 2013 · national
Continuity (1)
Related Publication 20150018533A1 · Jan 15, 2015